CV Sciences, Inc. (CVSI)

0.02 +0.00% (+0.00)

Over 5Y: -93.3%

2026-08-28
0.1 0.2 0.3
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '25 — Revenue: 3.3M Q3 '25 — Operating Cash Flow: -259K Q3 '25 — Free Cash Flow: -270K Q3 '25 — Net Income: -382K Q4 '25 — Revenue: 3.3M Q4 '25 — Operating Cash Flow: -354K Q4 '25 — Free Cash Flow: -363K Q4 '25 — Net Income: -206K Q1 '26 — Revenue: 3.2M Q1 '26 — Operating Cash Flow: 101K Q1 '26 — Free Cash Flow: 98K Q1 '26 — Net Income: -643K Q2 '26 — Revenue: 3M Q2 '26 — Operating Cash Flow: 20K Q2 '26 — Free Cash Flow: 13K Q2 '26 — Net Income: -775K 0 900K 1.8M 2.7M 3.6M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.2
OE margin -8.4%
Oper. margin -7.6%
ROIC -25.8%
Accruals -23.2%
Gross margin 49.1%
FCF margin -4.1%
OCF margin -3.9%
Profit margin -15.7%
ROA -30.8%
ROCE -61.4%
ROE -127.7%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.4
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.99×
Cash / Debt 0.16×
Debt / Eq 1.1×
Net debt / Eq 0.89×
F-score 4.0 pts
Quick ratio 0.18×
Cash runway —
Debt payback —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.0
Sales/sh Y/Y -18.9%
Sales Q/Q -17.5%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.